Stay updated with breaking news from Cell Gene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BCMA-CD19 compound CAR (cCAR) therapy was safe and well tolerated and achieved proof of concept of complete humoral reset delivering long-term medication-free remission - iCell's BCMA-CD19 cCAR
/PRNewswire/ -- DelveInsight's CAR T-Cell Therapy Market Insights report includes a comprehensive understanding of current treatment practices, emerging CAR...
Dublin, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Allogeneic Cell Therapy Market: Distribution by Type of Cell Therapy, Source of Cell, Target...
/PRNewswire/ -- The "Allogeneic Cell Therapy: Global Market Report 2023-2035" report has been added to ResearchAndMarkets.com's offering. The global allogeneic...
DUBLIN--(BUSINESS WIRE)--The "CAR T - Cell Therapy - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 250+ companies and 500+ drugs in CAR T - Cell Therapy Competitive landscape. It covers the therapeutics assessment by product...